Braveheart Investment Group Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Trevor Brown

Algemeen directeur

UK£133.0k

Totale compensatie

Percentage CEO-salaris	100.0%
Dienstverband CEO	9.3yrs
Eigendom CEO	24.8%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	5.5yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Trevor Brown's beloning veranderd ten opzichte van Braveheart Investment Group's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-UK£6m
Jun 30 2024	n/a	n/a	-UK£7m
Mar 31 2024	UK£133k	UK£133k	-UK£7m
Dec 31 2023	n/a	n/a	-UK£3m
Sep 30 2023	n/a	n/a	UK£1m
Jun 30 2023	n/a	n/a	UK£1m
Mar 31 2023	UK£106k	UK£106k	UK£2m
Dec 31 2022	n/a	n/a	UK£184k
Sep 30 2022	n/a	n/a	-UK£1m
Jun 30 2022	n/a	n/a	UK£333k
Mar 31 2022	UK£127k	n/a	UK£2m
Dec 31 2021	n/a	n/a	UK£9m
Sep 30 2021	n/a	n/a	UK£16m
Jun 30 2021	n/a	n/a	UK£15m
Mar 31 2021	UK£117k	n/a	UK£14m
Sep 30 2020	n/a	n/a	UK£19k
Jun 30 2020	n/a	n/a	-UK£278k
Mar 31 2020	UK£72k	n/a	-UK£576k

Compensatie versus markt: De totale vergoeding ($USD 166.68K ) Trevor } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 354.22K ).

Compensatie versus inkomsten: De vergoeding van Trevor is gestegen terwijl het bedrijf verliesgevend is.

CEO

Trevor Brown (78 yo)

9.3yrs

Tenure

UK£133,021

Compensatie

Mr. Trevor Edward Brown, MBA, served as a an Executive Director of Strategy & Executive Director at Chamberlin plc and served its Non-Executive Director since 2021 until March 5, 2024 & serves as it's Non-...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Trevor Brown	CEO & Non-Executive Director	10.6yrs	UK£133.02k	24.83% £ 632.8k
Vivian Hallam	COO & Executive Director	7.4yrs	UK£148.52k	2.21% £ 56.4k
Qu Li	Independent Non-Executive Director	3.4yrs	UK£35.12k	geen gegevens
Susan Hagan	Non-Executive Director	3.5yrs	UK£36.17k	geen gegevens

5.5yrs

Gemiddelde duur

63.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BRH wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.5 jaar).

Braveheart Investment Group Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

CEO & Non-Executive Director recently bought UK£91k worth of stock

Insufficient new directors

Braveheart Investment Group plc, Annual General Meeting, Jul 18, 2024

Braveheart Investment Group plc, Annual General Meeting, Jul 28, 2023

Less than half of directors are independent

Less than half of directors are independent

Recent updates

CEO & Non-Executive Director recently bought UK£91k worth of stock

First half 2025 earnings released: EPS: UK£0.001 (vs UK£0.011 loss in 1H 2024)

Braveheart Investment Group plc (AIM:BRH) acquired 29.51% stake in IQ-AI Limited (LSE:IQAI) from Trevor Brown and Free Association Books Limited for £0.719 million.

Braveheart Investment Group plc (AIM:BRH) acquired an additional 15% stake in Gyrometric Systems Limited for £0.0225 million.

Insufficient new directors

Full year 2024 earnings released: UK£0.11 loss per share (vs UK£0.027 profit in FY 2023)

Braveheart Investment Group plc, Annual General Meeting, Jul 18, 2024

Bruker Uk Limited completed the acquisition of Phasefocus Holdings Limited from Braveheart Investment Group plc (AIM:BRH) and other shareholders.

Bruker Uk Limited entered into a conditional sale and purchase agreement to acquire Phasefocus Holdings Limited from Braveheart Investment Group plc (AIM:BRH) and other shareholders for £5 million.

First half 2024 earnings released: UK£0.011 loss per share (vs UK£0.01 loss in 1H 2023)

New minor risk - Share price stability

New major risk - Market cap size

Braveheart Investment Group plc, Annual General Meeting, Jul 28, 2023

Full year 2023 earnings released: EPS: UK£0.027 (vs UK£0.031 in FY 2022)

Less than half of directors are independent

First half 2023 earnings released: UK£0.012 loss per share (vs UK£0.049 profit in 1H 2022)

Braveheart Investment Group plc (AIM:BRH) acquired additional 4.7% stake in Autins Group plc (AIM:AUTG) for £0.16 million.

Braveheart Investment Group plc (AIM:BRH) acquired additional 8.31% minority stake in Aukett Swanke Group Plc (AIM:AUK) from Andrew Murdoch for £0.33 million.

Braveheart Investment Group plc (AIM:BRH) agreed to acquire a 7.89% stake in Aukett Swanke Group Plc (AIM : AUK) from Trevor Brown for £0.22 million.

Braveheart Investment Group plc Provides the Update on Paraytec

Full year 2022 earnings released: EPS: UK£0.031 (vs UK£0.37 in FY 2021)

Less than half of directors are independent

Less than half of directors are independent

First half 2022 earnings released: EPS UK£0.049 (vs UK£0.013 in 1H 2021)

Braveheart Investment Group plc Announces Further Update re Paraytec AD Scanner Project

CEO & Director recently sold UK£556k worth of stock

Full year 2021 earnings released

Braveheart Investment Group plc Updates on the Paraytec AD Scanner Project

David Orton, Paul Orton and Janet Poliakoff agreed to acquire a 56.07% stake in Gyrometric Systems Limited from Braveheart Investment Group plc (AIM:BRH) and Remote Monitored Systems plc (AIM:RMS).

CEO & Director recently sold UK£827k worth of stock

Independent Non-Executive Director has left the company

CEO & Director recently sold UK£1.7m worth of stock

CEO & Director recently sold UK£689k worth of stock

New 90-day high: UK£0.80

Braveheart Investment Group plc Provides Update Concerning Progress to Develop Covid-19 Test That Paraytec Limited Is Working on in Conjunction with the University of Sheffield

CEO & Director recently sold UK£214k worth of stock

First half 2021 earnings released: EPS UK£0.013

New 90-day high: UK£0.47

New 90-day high: UK£0.37

Remote Monitored Systems plc (AIM:RMS) agree to acquire 51.72% stake in Pharm 2 Farm Limited from Braveheart Investment Group plc (AIM:BRH) for £1.2 million.

Braveheart Investment Group plc Update on the Pharm2farm Anti-Viral Mask Project

New 90-day high - UK£0.21

New 90-day high - UK£0.21

New 90-day high - UK£0.20

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd